SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007985
Filing Date
2024-05-13
Accepted
2024-05-13 16:57:50
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240331x10q.htm   iXBRL 10-Q 1743522
2 EX-10.1 tmb-20240331xex10d1.htm EX-10.1 88544
3 EX-31.1 tmb-20240331xex31d1.htm EX-31.1 9938
4 EX-31.2 tmb-20240331xex31d2.htm EX-31.2 9959
5 EX-32.1 tmb-20240331xex32d1.htm EX-32.1 5421
6 EX-32.2 tmb-20240331xex32d2.htm EX-32.2 5457
  Complete submission text file 0001558370-24-007985.txt   7018088

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20240331.xsd EX-101.SCH 33390
8 EX-101.CAL tmb-20240331_cal.xml EX-101.CAL 48730
9 EX-101.DEF tmb-20240331_def.xml EX-101.DEF 118399
10 EX-101.LAB tmb-20240331_lab.xml EX-101.LAB 301060
11 EX-101.PRE tmb-20240331_pre.xml EX-101.PRE 243891
64 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240331x10q_htm.xml XML 1428357
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40544 | Film No.: 24939990
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)